Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.

Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.

Item
http://www.wikidata.org/entity/Q37837982
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer.Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1.The proliferation marker thymidine kinase 1 in clinical useElevated serum thymidine kinase activity in canine splenic hemangiosarcoma*.
P2860

Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.

Item
http://www.wikidata.org/entity/Q37837982
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative aspects of the pro ...... an and canine tumour diseases.
@en
Comparative aspects of the pro ...... an and canine tumour diseases.
@nl
type
label
Comparative aspects of the pro ...... an and canine tumour diseases.
@en
Comparative aspects of the pro ...... an and canine tumour diseases.
@nl
prefLabel
Comparative aspects of the pro ...... an and canine tumour diseases.
@en
Comparative aspects of the pro ...... an and canine tumour diseases.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Comparative aspects of the pro ...... an and canine tumour diseases.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1476-5829.2010.00238.X
P433
P478
P577
P698